Portfolio Holdings Detail for ISIN IE00BDZVHG35
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) |
| Issuer | Blackrock |
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
| ETF Ticker | BTEE(USD) LSE |
| ETF Ticker | BTEE.L(GBP) LSE |
Holdings detail for AMRX
| Stock Name | Amneal Pharmaceuticals, Inc. Class A Common Stock |
| Ticker | AMRX(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US03168L1052 |
| LEI | 549300VV176ZO5WQHZ61 |
Show aggregate AMRX holdings
News associated with AMRX
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Bought by Principal Financial Group Inc.
- Principal Financial Group Inc. grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 9.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 96,835 shares of the company’s stock after purchasing an additional 8,213 shares during the quarter. Principal Financial Group Inc.’s holdings in Amneal Pharmaceuticals were worth $767,000 as […] - 2025-03-07 08:21:06
- Analysts Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Target Price at $10.60
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Buy” by the five research firms that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the […] - 2025-03-05 06:55:12
- Rhumbline Advisers Acquires 7,875 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
- Rhumbline Advisers boosted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 3.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 232,264 shares of the company’s stock after acquiring an additional 7,875 shares during the period. Rhumbline Advisers’ holdings in Amneal Pharmaceuticals were worth $1,840,000 as of its most recent SEC filing. […] - 2025-03-04 08:12:48
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Y Intercept Hong Kong Ltd
- Y Intercept Hong Kong Ltd lifted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 55.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,111 shares of the company’s stock after purchasing an additional 20,686 shares during the period. Y Intercept Hong Kong Ltd’s […] - 2025-03-03 08:28:58
- Amneal Pharmaceuticals (NASDAQ:AMRX) Rating Increased to Overweight at JPMorgan Chase & Co.
- Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a note issued to investors on Monday, Marketbeat Ratings reports. The firm presently has a $12.00 price objective on the stock, up from their previous price objective of $9.00. JPMorgan […] - 2025-02-26 07:01:03
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 18.0% in January
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,420,000 shares, a decline of 18.0% from the January 15th total of 2,950,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average […] - 2025-02-17 08:44:56
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.00 Average PT from Brokerages
- Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target […] - 2025-02-06 06:06:55
- Empirical Financial Services LLC d.b.a. Empirical Wealth Management Acquires 5,523 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
- Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 13.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 46,240 shares of the company’s stock after purchasing an additional 5,523 shares […] - 2025-01-30 08:57:13
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AMRX holdings
| Date | Number of AMRX Shares Held | Base Market Value of AMRX Shares | Local Market Value of AMRX Shares | Change in AMRX Shares Held | Change in AMRX Base Value | Current Price per AMRX Share Held | Previous Price per AMRX Share Held |
|---|
| 2025-03-12 (Wednesday) | 152,911 | USD 1,357,850 | USD 1,357,850 | 0 | USD 6,117 | USD 8.88 | USD 8.84 |
| 2025-03-11 (Tuesday) | 152,911 | USD 1,351,733 | USD 1,351,733 | 0 | USD 21,407 | USD 8.84 | USD 8.7 |
| 2025-03-10 (Monday) | 152,911 | USD 1,330,326 | USD 1,330,326 | 0 | USD -30,582 | USD 8.7 | USD 8.9 |
| 2025-03-07 (Friday) | 152,911 | USD 1,360,908 | USD 1,360,908 | -976 | USD 12,858 | USD 8.9 | USD 8.76 |
| 2025-03-06 (Thursday) | 153,887 | USD 1,348,050 | USD 1,348,050 | 0 | USD -32,316 | USD 8.76 | USD 8.97 |
| 2025-03-05 (Wednesday) | 153,887 | USD 1,380,366 | USD 1,380,366 | 0 | USD 20,005 | USD 8.97 | USD 8.84 |
| 2025-03-04 (Tuesday) | 153,887 | USD 1,360,361 | USD 1,360,361 | -488 | USD 8,036 | USD 8.84 | USD 8.76 |
| 2025-03-03 (Monday) | 154,375 | USD 1,352,325 | USD 1,352,325 | 0 | USD 13,894 | USD 8.76 | USD 8.67 |
| 2025-02-28 (Friday) | 154,375 | USD 1,338,431 | USD 1,338,431 | 0 | USD 44,768 | USD 8.67 | USD 8.38 |
| 2025-02-27 (Thursday) | 154,375 | USD 1,293,663 | USD 1,293,663 | 0 | USD -7,718 | USD 8.38 | USD 8.43 |
| 2025-02-26 (Wednesday) | 154,375 | USD 1,301,381 | USD 1,301,381 | 0 | USD -10,807 | USD 8.43 | USD 8.5 |
| 2025-02-25 (Tuesday) | 154,375 | USD 1,312,188 | USD 1,312,188 | 978 | USD 38,993 | USD 8.5 | USD 8.3 |
| 2025-02-24 (Monday) | 153,397 | USD 1,273,195 | USD 1,273,195 | 0 | USD 72,096 | USD 8.3 | USD 7.83 |
| 2025-02-21 (Friday) | 153,397 | USD 1,201,099 | USD 1,201,099 | 0 | USD -6,135 | USD 7.83 | USD 7.87 |
| 2025-02-20 (Thursday) | 153,397 | USD 1,207,234 | USD 1,207,234 | 0 | USD 3,068 | USD 7.87 | USD 7.85 |
| 2025-02-19 (Wednesday) | 153,397 | USD 1,204,166 | USD 1,204,166 | -488 | USD 5,402 | USD 7.85 | USD 7.79 |
| 2025-02-18 (Tuesday) | 153,885 | USD 1,198,764 | USD 1,198,764 | 0 | USD 9,233 | USD 7.79 | USD 7.73 |
| 2025-02-17 (Monday) | 153,885 | USD 1,189,531 | USD 1,189,531 | 0 | USD 0 | USD 7.73 | USD 7.73 |
| 2025-02-14 (Friday) | 153,885 | USD 1,189,531 | USD 1,189,531 | 0 | USD -27,699 | USD 7.73 | USD 7.91 |
| 2025-02-13 (Thursday) | 153,885 | USD 1,217,230 | USD 1,217,230 | 1,461 | USD 25,274 | USD 7.91 | USD 7.82 |
| 2025-02-12 (Wednesday) | 152,424 | USD 1,191,956 | USD 1,191,956 | 487 | USD -17,463 | USD 7.82 | USD 7.96 |
| 2025-02-11 (Tuesday) | 151,937 | USD 1,209,419 | USD 1,209,419 | 1,948 | USD 17,006 | USD 7.96 | USD 7.95 |
| 2025-02-10 (Monday) | 149,989 | USD 1,192,413 | USD 1,192,413 | 0 | USD 14,999 | USD 7.95 | USD 7.85 |
| 2025-02-07 (Friday) | 149,989 | USD 1,177,414 | USD 1,177,414 | 0 | USD -17,998 | USD 7.85 | USD 7.97 |
| 2025-02-06 (Thursday) | 149,989 | USD 1,195,412 | USD 1,195,412 | 0 | USD -1,500 | USD 7.97 | USD 7.98 |
| 2025-02-05 (Wednesday) | 149,989 | USD 1,196,912 | USD 1,196,912 | 0 | USD -1,500 | USD 7.98 | USD 7.99 |
| 2025-02-04 (Tuesday) | 149,989 | USD 1,198,412 | USD 1,198,412 | 0 | USD -28,498 | USD 7.99 | USD 8.18 |
| 2025-02-03 (Monday) | 149,989 | USD 1,226,910 | USD 1,226,910 | 0 | USD -11,999 | USD 8.18 | USD 8.26 |
| 2025-01-31 (Friday) | 149,989 | USD 1,238,909 | USD 1,238,909 | 0 | USD -47,997 | USD 8.26 | USD 8.58 |
| 2025-01-30 (Thursday) | 149,989 | USD 1,286,906 | USD 1,286,906 | 0 | USD -22,498 | USD 8.58 | USD 8.73 |
| 2025-01-29 (Wednesday) | 149,989 | USD 1,309,404 | USD 1,309,404 | 0 | USD 0 | USD 8.73 | USD 8.73 |
| 2025-01-28 (Tuesday) | 149,989 | USD 1,309,404 | USD 1,309,404 | 0 | USD -13,499 | USD 8.73 | USD 8.82 |
| 2025-01-27 (Monday) | 149,989 | USD 1,322,903 | USD 1,322,903 | 0 | USD 20,998 | USD 8.82 | USD 8.68 |
| 2025-01-24 (Friday) | 149,989 | USD 1,301,905 | USD 1,301,905 | 0 | USD -19,498 | USD 8.68 | USD 8.81 |
| 2025-01-23 (Thursday) | 149,989 | USD 1,321,403 | USD 1,321,403 | 0 | USD 43,497 | USD 8.81 | USD 8.52 |
| 2025-01-22 (Wednesday) | 149,989 | USD 1,277,906 | USD 1,277,906 | | | | |
| 2025-01-21 (Tuesday) | 149,989 | USD 1,283,906 | USD 1,283,906 | | | | |
| 2025-01-20 (Monday) | 149,989 | USD 1,238,909 | USD 1,238,909 | | | | |
| 2025-01-17 (Friday) | 149,989 | USD 1,238,909 | USD 1,238,909 | | | | |
| 2025-01-16 (Thursday) | 148,041 | USD 1,230,221 | USD 1,230,221 | | | | |
| 2025-01-15 (Wednesday) | 146,093 | USD 1,200,884 | USD 1,200,884 | | | | |
| 2025-01-14 (Tuesday) | 146,093 | USD 1,146,830 | USD 1,146,830 | | | | |
| 2025-01-13 (Monday) | 146,093 | USD 1,127,838 | USD 1,127,838 | | | | |
| 2025-01-10 (Friday) | 146,093 | USD 1,164,361 | USD 1,164,361 | | | | |
| 2025-01-09 (Thursday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-09 (Thursday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-09 (Thursday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-08 (Wednesday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-08 (Wednesday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-08 (Wednesday) | 147,067 | USD 1,185,360 | USD 1,185,360 | | | | |
| 2025-01-02 (Thursday) | 149,019 | USD 1,156,387 | USD 1,156,387 | | | | |
| 2024-12-30 (Monday) | 149,019 | USD 1,166,819 | USD 1,166,819 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of AMRX by Blackrock for IE00BDZVHG35
Show aggregate share trades of AMRX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-03-07 | SELL | -976 | | | 8.900* | | 8.28 Profit of 8,080 on sale |
| 2025-03-04 | SELL | -488 | | | 8.840* | | 8.22 Profit of 4,010 on sale |
| 2025-02-25 | BUY | 978 | | | 8.500* | | 8.14 |
| 2025-02-19 | SELL | -488 | | | 7.850* | | 8.18 Profit of 3,993 on sale |
| 2025-02-13 | BUY | 1,461 | | | 7.910* | | 8.29 |
| 2025-02-12 | BUY | 487 | | | 7.820* | | 8.32 |
| 2025-02-11 | BUY | 1,948 | | | 7.960* | | 8.35 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of AMRX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-03-13 | 137,565 | 1,263 | 924,075 | 14.9% |
| 2025-03-12 | 99,714 | 3 | 678,394 | 14.7% |
| 2025-03-11 | 118,797 | 0 | 309,614 | 38.4% |
| 2025-03-10 | 201,368 | 140 | 604,468 | 33.3% |
| 2025-03-07 | 203,652 | 317 | 853,969 | 23.8% |
| 2025-03-06 | 582,365 | 0 | 1,314,459 | 44.3% |
| 2025-03-05 | 264,745 | 134 | 817,561 | 32.4% |
| 2025-03-04 | 157,009 | 45 | 712,090 | 22.0% |
| 2025-03-03 | 232,405 | 30,864 | 1,006,604 | 23.1% |
| 2025-02-28 | 548,104 | 200 | 1,119,987 | 48.9% |
| 2025-02-27 | 150,674 | 11 | 541,350 | 27.8% |
| 2025-02-26 | 472,848 | 949 | 1,248,908 | 37.9% |
| 2025-02-25 | 131,948 | 12 | 345,382 | 38.2% |
| 2025-02-24 | 410,833 | 102 | 1,597,440 | 25.7% |
| 2025-02-21 | 119,024 | 0 | 258,311 | 46.1% |
| 2025-02-20 | 81,663 | 0 | 282,578 | 28.9% |
| 2025-02-19 | 122,220 | 0 | 299,381 | 40.8% |
| 2025-02-18 | 81,031 | 687 | 154,886 | 52.3% |
| 2025-02-14 | 68,193 | 2,400 | 160,987 | 42.4% |
| 2025-02-13 | 59,757 | 42 | 180,264 | 33.1% |
| 2025-02-12 | 72,966 | 6,505 | 161,576 | 45.2% |
| 2025-02-11 | 68,369 | 1 | 169,568 | 40.3% |
| 2025-02-10 | 148,578 | 324 | 508,250 | 29.2% |
| 2025-02-07 | 99,563 | 551 | 279,679 | 35.6% |
| 2025-02-06 | 89,138 | 101 | 505,127 | 17.6% |
| 2025-02-05 | 132,711 | 908 | 630,283 | 21.1% |
| 2025-02-04 | 160,299 | 0 | 724,411 | 22.1% |
| 2025-02-03 | 227,850 | 29,575 | 461,945 | 49.3% |
| 2025-01-31 | 247,041 | 0 | 446,050 | 55.4% |
| 2025-01-30 | 138,857 | 131 | 571,315 | 24.3% |
| 2025-01-29 | 58,325 | 1 | 145,770 | 40.0% |
| 2025-01-28 | 82,810 | 0 | 220,785 | 37.5% |
| 2025-01-27 | 166,470 | 263 | 457,997 | 36.3% |
| 2025-01-24 | 130,202 | 364 | 281,006 | 46.3% |
| 2025-01-23 | 191,850 | 1,408 | 542,332 | 35.4% |
| 2025-01-22 | 115,980 | 0 | 233,819 | 49.6% |
| 2025-01-21 | 123,886 | 0 | 1,034,292 | 12.0% |
| 2025-01-17 | 118,604 | 0 | 340,917 | 34.8% |
| 2025-01-16 | 201,013 | 0 | 727,925 | 27.6% |
| 2025-01-15 | 188,984 | 0 | 483,199 | 39.1% |
| 2025-01-14 | 104,628 | 0 | 201,244 | 52.0% |
| 2025-01-13 | 207,262 | 1,242 | 626,917 | 33.1% |
| 2025-01-10 | 86,836 | 0 | 161,703 | 53.7% |
| 2025-01-08 | 141,012 | 0 | 344,789 | 40.9% |
| 2025-01-07 | 166,826 | 4,053 | 316,873 | 52.6% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.